Similar articles for PMID: 23335566

Year	Number of Results
1975	1
1980	1
1982	1
1985	1
1987	1
1989	3
1991	1
1996	1
1997	1
1998	2
2000	3
2001	1
2002	5
2003	8
2005	4
2006	5
2007	5
2008	9
2009	13
2010	10
2011	13
2012	12
2013	24
2014	25
2015	19
2016	11
2017	14
2018	11
2019	8
2020	4
2021	4
2022	2
2023	1
2024	0

1

Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs.

Kieler-Ferguson HM, Fréchet JM, Szoka FC Jr. Kieler-Ferguson HM, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Mar-Apr;5(2):130-8. doi: 10.1002/wnan.1209. Epub 2013 Jan 17. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013. PMID: 23335566 Review.

2

Liposomal drug delivery systems: from concept to clinical applications.

Allen TM, Cullis PR. Allen TM, et al. Adv Drug Deliv Rev. 2013 Jan;65(1):36-48. doi: 10.1016/j.addr.2012.09.037. Epub 2012 Oct 1. Adv Drug Deliv Rev. 2013. PMID: 23036225 Review.

3

Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.

Li Y, Lu H, Liang S, Xu S. Li Y, et al. ACS Appl Mater Interfaces. 2019 Jun 12;11(23):20649-20659. doi: 10.1021/acsami.9b03960. Epub 2019 May 31. ACS Appl Mater Interfaces. 2019. PMID: 31117440

4

Cancer nanomedicines: so many papers and so few drugs!

Venditto VJ, Szoka FC Jr. Venditto VJ, et al. Adv Drug Deliv Rev. 2013 Jan;65(1):80-8. doi: 10.1016/j.addr.2012.09.038. Epub 2012 Oct 1. Adv Drug Deliv Rev. 2013. PMID: 23036224 Free PMC article. Review.

5

Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.

Silva H, Silva AC, Lemos FO, Monte-Neto RL, Fontes AP, Lopes MT, Frézard F. Silva H, et al. Anticancer Drugs. 2013 Feb;24(2):131-9. doi: 10.1097/CAD.0b013e3283599a34. Anticancer Drugs. 2013. PMID: 23011234

6

Liposomal nanomedicine for breast cancer therapy.

Paliwal SR, Paliwal R, Agrawal GP, Vyas SP. Paliwal SR, et al. Nanomedicine (Lond). 2011 Aug;6(6):1085-100. doi: 10.2217/nnm.11.72. Nanomedicine (Lond). 2011. PMID: 21955078 Review.

7

Liposomal nanomedicines.

Fenske DB, Cullis PR. Fenske DB, et al. Expert Opin Drug Deliv. 2008 Jan;5(1):25-44. doi: 10.1517/17425247.5.1.25. Expert Opin Drug Deliv. 2008. PMID: 18095927 Review.

8

Designing polymer conjugates as lysosomotropic nanomedicines.

Duncan R. Duncan R. Biochem Soc Trans. 2007 Feb;35(Pt 1):56-60. doi: 10.1042/BST0350056. Biochem Soc Trans. 2007. PMID: 17233601 Review.

9

Polymeric drug delivery of platinum-based anticancer agents.

Haxton KJ, Burt HM. Haxton KJ, et al. J Pharm Sci. 2009 Jul;98(7):2299-316. doi: 10.1002/jps.21611. J Pharm Sci. 2009. PMID: 19009590 Review.

10

Liposomal nanomedicines in the treatment of prostate cancer.

Kroon J, Metselaar JM, Storm G, van der Pluijm G. Kroon J, et al. Cancer Treat Rev. 2014 May;40(4):578-84. doi: 10.1016/j.ctrv.2013.10.005. Epub 2013 Oct 25. Cancer Treat Rev. 2014. PMID: 24216226 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

205 results

Results by year